Preoperative systemic levels of VEGFA, IL‐7, IL‐17A, and TNF‐β delineate two distinct groups of children with brain tumors

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Pediatric Blood & Cancer

• Publication date

  2016-07-29

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/pbc.26158PMID 27472224
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• BID Mediates Oxygen-Glucose Deprivation-Induced Neuronal Injury in Organotypic Hippocampal Slice Cultures and Modulates Tissue Inflammation in a Transient Focal Cerebral Ischemia Model without Changing Lesion Volume

  2016cited by this paper
• Reductions in circulating levels of IL-16, IL-7 and VEGF-A in myalgic encephalomyelitis/chronic fatigue syndrome.

  2016cited by this paper
• MethPed: an R package for the identification of pediatric brain tumor subtypes

  2016cited by this paper
• Immunosuppressive mechanisms in glioblastoma.

  2015cited by this paper
• Down-regulation of IKKβ expression in glioma-infiltrating microglia/macrophages is associated with defective inflammatory/immune gene responses in glioblastoma

  2015cited by this paper
• MethPed: a DNA methylation classifier tool for the identification of pediatric brain tumor subtypes

  2015cited by this paper
• Tetanus toxoid and CCL3 improve DC vaccines in mice and glioblastoma patients

  2015cited by this paper
• IL-17 promoted the inhibition of medulloblastoma in mice by splenocyte injection

  2015cited by this paper
• Aberrant immunostaining pattern of the CD24 glycoprotein in clinical samples and experimental models of pediatric medulloblastomas

  2015cited by this paper
• A pilot microdialysis study in brain tumor patients to assess changes in intracerebral cytokine levels after craniotomy and in response to treatment with a targeted anti-cancer agent

  2014cited by this paper
• Tumor-Associated Macrophages in SHH Subgroup of Medulloblastomas

  2014cited by this paper
• Phase 2 study of safety and efficacy of nimotuzumab in pediatric patients with progressive diffuse intrinsic pontine glioma.

  2014cited by this paper
• Quantitative expression of serum biomarkers involved in angiogenesis and inflammation, in patients with glioblastoma multiforme: Correlations with clinical data

  2014cited by this paper
• T-cell TGF-β signaling abrogation restricts medulloblastoma progression

  2014cited by this paper
• Molecular sub-group-specific immunophenotypic changes are associated with outcome in recurrent posterior fossa ependymoma

  2014cited by this paper
• Analysis of CD137L and IL-17 Expression in Tumor Tissue as Prognostic Indicators for Gliblastoma

  2013cited by this paper
• Elevated CD3+ and CD8+ tumor-infiltrating immune cells correlate with prolonged survival in glioblastoma patients despite integrated immunosuppressive mechanisms in the tumor microenvironment and at the systemic level.

  2013cited by this paper
• Characterization of Distinct Immunophenotypes across Pediatric Brain Tumor Types

  2013cited by this paper
• A neuro-immune model of Myalgic Encephalomyelitis/Chronic fatigue syndrome

  2013cited by this paper
• Robust molecular subgrouping and copy-number profiling of medulloblastoma from small amounts of archival tumour material using high-density DNA methylation arrays

  2013cited by this paper
• Differential expression and methylation of brain developmental genes define location-specific subsets of pilocytic astrocytoma

  2013cited by this paper
• CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2007-2011.

  2012cited by this paper
• Accessories to the crime: functions of cells recruited to the tumor microenvironment.

  2012cited by this paper
• Hotspot mutations in H3F3A and IDH1 define distinct epigenetic and biological subgroups of glioblastoma.

  2012cited by this paper
• Increased Immune Gene Expression and Immune Cell Infiltration in High-Grade Astrocytoma Distinguish Long-Term from Short-Term Survivors

  2012cited by this paper
• Multiplex measurement of proinflammatory cytokines in human serum: comparison of the Meso Scale Discovery electrochemiluminescence assay and the Cytometric Bead Array.

  2011cited by this paper
• Delineation of two clinically and molecularly distinct subgroups of posterior fossa ependymoma.

  2011cited by this paper
• Medulloblastoma comprises four distinct molecular variants.

  2011cited by this paper
• TH1 predominance is associated with improved survival in pediatric medulloblastoma patients

  2011cited by this paper
• Immunity, inflammation, and cancer.

  2010cited by this paper
• The Role of T-Helper 17 (Th17) Cells in Patients with Medulloblastoma

  2010cited by this paper
• T helper 17 cells promote cytotoxic T cell activation in tumor immunity.

  2009cited by this paper
• Targeted depletion of lymphotoxin-alpha-expressing Th1 and Th17 cells inhibits autoimmune disease (48.22)

  2009cited by this paper
• Immune Gene and Cell Enrichment Is Associated with a Good Prognosis in Ependymoma1

  2009cited by this paper
• Validation and comparison of two multiplex technologies, Luminex and Mesoscale Discovery, for human cytokine profiling.

  2009cited by this paper
• Targeted depletion of lymphotoxin-α–expressing TH1 and TH17 cells inhibits autoimmune disease

  2009cited by this paper
• Tumor-specific Th17-polarized cells eradicate large established melanoma.

  2008cited by this paper
• Central nervous system tumors.

  2007cited by this paper
• Incident reporting and patient safety

  2007cited by this paper
• Comparative analysis of peripheral and localised cytokine secretion in glioblastoma patients.

  2007cited by this paper
• Th1/Th2 cytokine imbalance in meningioma, anaplastic astrocytoma and glioblastoma multiforme patients.

  2006cited by this paper
• An adoptive immunotherapy of patients with medulloblastoma by lymphokine-activated killer cells (LAK)

  2005cited by this paper
• Altered Expression of Immune Defense Genes in Pilocytic Astrocytomas

  2005cited by this paper
• Results of a phase 1 study utilizing monocyte-derived dendritic cells pulsed with tumor RNA in children and young adults with brain cancer.

  2004cited by this paper
• Genetic and Plasma Markers of Venous Thromboembolism in Patients with High Grade Glioma

  2004cited by this paper
• Bioanalytical Method Validation

  2004cited by this paper
• Angiogenic profile of childhood primitive neuroectodermal brain tumours/medulloblastomas.

  2001cited by this paper
• Serum levels of IL-7 in bone marrow transplant recipients: relationship to clinical characteristics and lymphocyte count

  1999cited by this paper
• Central nervous system tumors.

  1987cited by this paper
• Accessories to the Crime: Functions of Cells Recruited to the Tumor Microenvironment Prospects and Obstacles for Therapeutic Targeting of Function-enabling Stromal Cell Types

  year unknowncited by this paper

• Characterizing CSF inflammatory proteomics in pediatric post-hemorrhagic hydrocephalus and Anti-NMDAR encephalitis

  2025cites this paper
• Tumor Dormancy and Reactivation: The Role of Heat Shock Proteins

  2024cites this paper
• From lymphopenia to restoration: IL-7 immunotherapy for lymphocyte recovery in glioblastoma.

  2024cites this paper
• Immunobiology and Cytokine Modulation of the Pediatric Brain Tumor Microenvironment: A Scoping Review

  2023cites this paper
• Dynamic analysis of immune status in patients with intracranial germ cell tumor and establishment of an immune risk prognostic model

  2022cites this paper
• STOP Pain Project—Opioid Response in Pediatric Cancer Patients and Gene Polymorphisms of Cytokine Pathways

  2022cites this paper
• Targeting Angiogenic Factors for the Treatment of Medulloblastoma

  2022cites this paper
• Immunosuppression in Medulloblastoma: Insights into Cancer Immunity and Immunotherapy

  2021cites this paper
• Interleukin (IL)-7 Signaling in the Tumor Microenvironment.

  2021cites this paper
• Changes in peripheral blood regulatory T cells, and IL-6 and IL-10 levels predict response of pediatric medulloblastoma and germ cell tumors with residual or disseminated disease to craniospinal irradiation.

  2021cites this paper
• Development of a prognostic model based on an immunogenomic landscape analysis of medulloblastoma

  2020cites this paper
• Immunoinformatics

  2020cites this paper
• Multiplexing of Immune Markers via Electrochemiluminescence Immunoassays for Systems Biology.

  2020cites this paper
• VEGF levels in patients with glioma: a systematic review and meta-analysis

  2020cites this paper
• Transcriptional co-expression regulatory network analysis for Snail and Slug identifies IL1R1, an inflammatory cytokine receptor, to be preferentially expressed in ST-EPN-RELA and PF-EPN-A molecular subgroups of intracranial ependymomas

  2018cites this paper
• Potential role of CSF cytokine profiles in discriminating infectious from non-infectious CNS disorders

  2018cites this paper
• Affinity assays for profiling disease-associated proteins in human plasma

  2017cites this paper
• MiR-15a-5p regulates viability and matrix degradation of human osteoarthritis chondrocytes via targeting VEGFA.

  2016cites this paper
• Integrated Analysis of Serum Lymphocytes Develops a Nomogram for Predicting Prognosis of Intracranial Germ Cell Tumors to Chemo-Radiotherapy

  year unknowncites this paper